The injection delivers B12 directly into the bloodstream, making it the most reliable method for patients with absorption problems, pernicious anaemia, or gastrointestinal conditions affecting B12 uptake (such as Crohn's disease, coeliac disease, or following gastric surgery)
For a clinic that injects patients, there is added risk: administering a product that has not been assessed for identity, purity or sterility can cause real harm, and the clinic, not the overseas supplier, is the party a regulator and an injured patient will pursue
That asymmetry has made BPC-157 unusual in the peptide landscape: widely used, extensively studied preclinically, yet almost entirely untested under controlled human conditions
A systematic review published in 2025 identified 544 total articles on BPC-157 published between 1993 and 2024, filtering to 36 studies meeting inclusion criteria
ERR Agonist Exercise mimetic for endurance support
Always consult with a qualified healthcare professional before using any peptide or supplement
.webp)
